In January 2023, the Brukinsa, a next-generation BTK inhibitor, received FDA approval for chronic lymphocytic leukemia (CLL).

The Capital Region Big Climb is now set for Saturday, May 3, announced Albany County Executive Daniel P. McCoy, the Albany County Sheriff Craig Apple and representatives of ...

A group of local students has spent the last several weeks raising hundreds of thousands of dollars for the Leukemia and ...

The global large granular lymphocytic leukemia therapeutics market is poised for significant expansion over the next decade, underpinned by improvements in diagnostic capabilities, the development of ...